Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HY-16462 |
Synonyms | |
Therapy Description |
HY-16462 is a CDK9 inhibitor, which has potential antitumor activity (PMID: 31000582). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HY-16462 | HY16462|HY 16462 | CDK9 Inhibitor 21 | HY-16462 is a CDK9 inhibitor, which has potential antitumor activity (PMID: 31000582). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|